Optic Neuritis Withdrawn Phase 4 Trials for Methotrexate (DB00563)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

DBCOND0027863 (Optic Neuritis)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00037115Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.Treatment